Research Overview of PT-141
PT-141 is a synthetic cyclic heptapeptide derived from the melanocortin peptide melanotan II, designed specifically for in-vitro laboratory research into melanocortin receptor pathways. This peptide demonstrates selective agonist activity at melanocortin-3 and melanocortin-4 receptors in preclinical models, making it valuable for researchers investigating neural pathway modulation and receptor binding mechanisms. Scientists studying melanocortin signalling cascades often examine this compound’s interaction with hypothalamic circuits and autonomic nervous system responses in controlled laboratory environments.
Laboratory Research Applications
Research teams investigating melanocortin receptor biology frequently examine PT-141’s mechanism of action across various experimental models. The peptide’s unique ability to penetrate the blood-brain barrier in animal studies makes it particularly interesting for researchers studying central nervous system melanocortin pathways. Published studies have documented its effects on neural activation patterns in rodent models, with researchers at Stroid UK Shop investigating its potential applications in neuropharmacology. Scientists working with melanocortin receptor research often compare PT-141’s binding affinity profiles against other melanocortin agonists. The compound’s selectivity for MC3/MC4 receptors distinguishes it from broader-spectrum melanocortin peptides, allowing researchers to study specific receptor subtype functions. Advanced research protocols examining autonomic nervous system modulation frequently incorporate this peptide alongside other research compounds from our extensive catalogue. Laboratory studies investigating neural pathway activation patterns often utilise PT-141 in conjunction with other research peptides available through our peptide research collection.
Technical Specifications
| Parameter | Value |
|---|---|
| Chemical Name | Bremelanotide |
| CAS Number | 189691-06-3 |
| Molecular Formula | C50H68N14O10 |
| Molecular Weight | 1025.16 g/mol |
| Peptide Sequence | Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH |
| Form | Lyophilised Powder |
| Purity | ≥98% (HPLC) |
| Storage | -20°C, Protected from Light |
Research Compliance Statement
PT-141 10mg Generic is supplied exclusively for in-vitro laboratory research purposes and is not intended for human consumption, clinical trials, or therapeutic applications. This research peptide must be handled by qualified laboratory personnel in appropriate research facilities following institutional biosafety protocols. Researchers should maintain proper storage conditions and documentation as required by their institutional review boards and regulatory oversight bodies.
